Thomas P. O'Neil, Chief Financial Officer at Satsuma Pharmaceuticals, Inc. (STSA), sold 2,000 shares at $25.00 ($50K) on 2020-05-20, disclosed to the SEC on 2020-05-21.
Open-market sale of $50k STSA by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| STSA | SELL | 2020-07-02 | $27K | — | Filing → |
| STSA | SELL | 2020-06-24 | $149K | — | Filing → |
| STSA | SELL | 2020-06-02 | $25K | — | Filing → |